Dr. Robert Lanford, PhD, is currently a Scientist at the Texas Biomedical Research Institute, the Leader of the Infectious Disease and Biodefense Group of the Southwest National Primate Research Center, and an Adjunct Professor at the University of Texas Health Science Center. Dr. Robert E. Lanford received a B.S. degree from the University of Texas in 1974 and a Ph.D. in Virology from Baylor College of Medicine in 1979. He served as faculty at Baylor College of Medicine until 1984 when he moved to the Southwest Foundation for Biomedical Research to initiate programs on the use of nonhuman primates as models for human hepatitis infections. Dr. Lanford has published over 140 scientific papers and serves as a reviewer and editorial board member for several journals. His laboratory performs research on HAV, HBV, HCV and GBV-B. One of the primary goals of his research program is to better understand the interactions of the virus with the host, and how these interactions influence either viral clearance or persistence and disease progression. His studies in the chimpanzee were the first to use total genome microarray analysis to examine viral-host interactions and the innate immune response to HCV. In collaboration with pharmaceutical companies, he has utilized the chimpanzee model of chronic HBV and HCV infections to evaluate efficacy of new antiviral therapies as the last preclinical step prior to human clinical trials.